We reviewed laboratory-acquired infections occurring in Utah from 1978 through 1982. Written and telephone interviews of supervisors of 1,191 laboratorians revealed an estimated annual incidence of 3 laboratory-acquired infections per 1,000 employees. Infections, in order of frequency, included hepatitis B (clinical cases), shigellosis, pharyngitis, cellulitis, tuberculosis (skin test conversion), conjunctivitis, and non-A, non-B hepatitis. One-half of large laboratories (over 25 employees), but only 12% of smaller laboratories, reported infections. The annual incidence, however, at smaller laboratories was more than three times greater than at large laboratories (5.0 versus 1.5 per 1,000; P less than 0.05, chi-square test). Microbiologists were at greatest risk of infection, with an incidence of almost 1%, followed by generalists and phlebotomists. Shigellosis was acquired only by microbiologists and accounted for more than half of their infections. The most common laboratory-acquired infection, hepatitis B, affected a microbiologist, a hematologist, a phlebotomist, a pulmonary blood gas technician, and a blood bank technologist who died from her illness. Clinical cases of hepatitis B occurred at a rate 10 times higher than the rate in the general U.S. population. The incidence of tuberculosis skin test conversion was intermediate between rates reported for hospital employees and for the state of Utah.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC271701PMC
http://dx.doi.org/10.1128/jcm.21.4.486-489.1985DOI Listing

Publication Analysis

Top Keywords

laboratory-acquired infections
8
annual incidence
8
clinical cases
8
tuberculosis skin
8
skin test
8
test conversion
8
large laboratories
8
smaller laboratories
8
infections
6
laboratories
5

Similar Publications

Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023.

Can Commun Dis Rep

January 2025

Regulatory, Operations and Emergency Management Branch, Public Health Agency of Canada, Ottawa, ON.

Background: The Public Health Agency of Canada oversees the and , and monitors human pathogen and toxin incidents in licensed facilities to minimize exposure impact at the individual and population level.

Objective: To provide an overview of confirmed laboratory exposure incidents in Canada in 2023.

Methods: Confirmed exposure incident reports in 2023 were analyzed using R 4.

View Article and Find Full Text PDF

Prevalence of Multiple RNA Virus Infections in Nine Types of Commonly Used Laboratory Animals in China.

Zoonoses Public Health

January 2025

Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, People's Republic of China.

Introduction: Laboratory animals are widely used in biomedical research. Surveillance of naturally occurring virus in laboratory animals is important to fully understand the results of animal experiment, control laboratory-acquired infections among research personnel and manage viral transmission within laboratory animal populations. This study aimed to investigate the prevalence of multiple RNA viruses in laboratory animals commonly used in China.

View Article and Find Full Text PDF

Brucellosis is a zoonosis with non-specific clinical symptoms involving multiple systems and organs. Its prevalence is low in most of EU countries, which can lead to the difficulties in laboratory and clinical diagnostic. Due to its relationship to the Ochrobactrum spp.

View Article and Find Full Text PDF
Article Synopsis
  • Fungi are classified into four Risk Groups based on their potential to harm humans, with Risk Group 3 indicating significant dangers, including fatalities.
  • This review highlights dangerous fungi like Blastomyces dermatitidis and Cladophialophora bantiana, which are known for severe health impacts and high mortality rates due to laboratory-acquired infections.
  • Strict biosafety measures are essential in labs handling these fungi due to their associated risks and documented cases of infections and deaths.
View Article and Find Full Text PDF

Laboratory-acquired infection in clinical laboratories and the incidence rate after Brucella exposure risk events: a systematic review and meta-analysis.

J Hosp Infect

January 2025

Department of Hospital Infection Management, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address:

Background: Personnel in clinical microbiology laboratories face heightened risks of occupational infections, due to the potential for pathogenicity in clinical samples.

Aim: To summarize the characteristics of laboratory-acquired infections (LAIs) and review exposure incidents in clinical laboratories, and to conduct a meta-analysis to estimate post-exposure incidence rates and evaluate the efficacy of post-exposure prophylaxis (PEP) following Brucella exposures.

Methods: A systematic search across PubMed, Embase, Web of Science, CNKI, Wanfang, CMB, and the ABSA LAI database extracted relevant literature published from January 1, 1990, to August 31, 2023, including case reports and laboratory exposure risk events.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!